• Home
• Responsibility
• CR Review 2006

Corporate Responsibility Review 2006

Introduction

Welcome to GlaxoSmithKline’s Corporate Responsibility Review 2006. This Review explains our approach to some of the key social, ethical and environmental issues associated with our business and gives an overview of our performance in 2006.

About GSK
We are a research-based pharmaceutical company. Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Our business employs over 100,000 people in 116 countries. Our Consumer Healthcare business includes dental health products, over-the-counter medicines and nutritional drinks.

Why is CR important to GSK?
Corporate responsibility is about how we achieve our goals and implement our four business strategies. We aim to operate in a way that reflects our values and to connect business decisions to ethical, social and environmental concerns.

This helps us to achieve our business goals by:

• Improving our ability to attract, retain and motivate the best people
• Supporting our relationships with key stakeholders, including patients and consumers, doctors and governments
• Strengthening our risk management processes
• Protecting and enhancing our reputation and therefore trust in our products.

We believe that our business makes a valuable contribution to society by developing and marketing medicines which improve people’s lives. However we know that the research, development, manufacture and sale of medicines raise ethical issues. We seek to minimize the negative impacts of our business and maximize the positive benefits of our products and operations. This CR Review and our full CR Report explain our approach.

Our full corporate responsibility report
This Review is intended to provide an overview of our key corporate responsibility issues. It is not a complete account of our performance in 2006.

Our full CR Report is available as a pdf download. This includes information on how we apply our environmental, health and safety, and human rights standards in our supply chain.

Turnover by location of customer 2006

Key statistics

(£ billion)	2006	2005	2004
Turnover
Total	23.2	21.7	20.0
Pharmaceuticals	20.1	18.7	17.1
Consumer healthcare	3.1	3.0	2.9
Profit before taxation	7.8	6.7	5.8

Medicines

Vaccines

Consumer healthcare brands